NCT03267498: A reported trial by Sue Yom
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03267498 |
|---|---|
| Title | Nivolumab in Combination With Chemoradiation for Patients With Stage II-IVB Nasopharyngeal Carcinoma, A Phase II Study With Correlative Biomarkers |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Feb. 14, 2018 |
| Completion date | Oct. 31, 2024 |
| Required reporting date | Oct. 31, 2025, midnight |
| Actual reporting date | Oct. 31, 2025 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |